Recent reports of babies born with opioid withdrawal symptoms after their mothers used kratom during pregnancy have generated much concern about the medicinal herb.

A newly expanded genetic alphabet that includes four synthetic nucleotides highlights the need for strict boundaries on their use.

The agency sends warning letters to makers of products that claim to prevent or treat Alzheimer’s and other diseases, and announces changes to its enforcement practices.

Two professors have been arrested for negligence in connection with the blast.

The European Court of Justice has decided that organisms made with precision techniques such as CRISPR will be subject to the same rules as transgenic plants or animals.

Vanessa Allen Sutherland will resign next month, leaving the agency with just three members of what should be a five-person board.

Two patients became legally blind after receiving treatments at the facilities.

Cell implants, gene therapy, even optogenetics are making headway in clinical trials to treat various forms of blindness.  

The pre-peer review assessment finds the compound has “minimal effects,” but endocrinologists and others say key data have yet to come out.